MedPath

Lipoic acid

Generic Name
Lipoic acid
Drug Type
Small Molecule
Chemical Formula
C8H14O2S2
CAS Number
1200-22-2
Unique Ingredient Identifier
VLL71EBS9Z

Overview

A vitamin-like antioxidant.

Indication

For nutritional supplementation, also for treating dietary shortage or imbalance.

Associated Conditions

  • Diabetic Neuropathies
  • Type 2 Diabetes Mellitus

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/03/25
Not Applicable
Completed
2024/11/25
Phase 2
Recruiting
2024/05/17
Phase 3
Recruiting
2024/02/29
Phase 3
ENROLLING_BY_INVITATION
2024/01/08
Not Applicable
Completed
Lu Jiang
2023/11/14
Phase 2
Completed
Khyber Medical University Peshawar
2023/04/12
Phase 2
Recruiting
2023/02/06
Phase 2
Not yet recruiting
2022/05/11
Phase 3
Completed
2022/03/04
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
MAS Management Group Inc.
69677-050
ORAL
150 mg in 1 1
8/11/2015
Pure Source, LLC
65121-301
ORAL
150 mg in 1 1
11/22/2023
Exeltis USA, Inc.
0642-0207
ORAL
15 mg in 1 1
1/2/2023
Deseret Biologicals, Inc.
43742-2259
ORAL
8 [hp_X] in 1 mL
4/8/2025
King Bio Inc.
57955-9001
ORAL
10 [hp_X] in 59 mL
5/19/2025
Parasitology Center Inc.
70321-0003
ORAL
8 [hp_X] in 1 mL
5/22/2025
Parasitology Center, Inc.
70321-0002
ORAL
8 [hp_C] in 1 mL
5/22/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
MaxN-Fuze Multivitamins
288444
Max Health & Living Australia Pty Ltd
Medicine
A
5/1/2017
Olivenol livin' Youthful
154944
10B Wellness Pty Limited
Medicine
A
9/4/2008
Orthoplex Clinical C
299281
Medicine
A
2/2/2018
Orthoplex Ultra Buffered C Powder
317425
Medicine
A
5/10/2019
Sugar Balance
314136
Medicine
A
2/11/2019
USANA HealthPak
350153
Medicine
A
11/30/2020
EFA Krill
422250
Medicine
A
9/22/2023
Natural BIOEGT Longevity & Beauty
458086
Medicine
A
8/1/2024
EHT Brain Formula
405416
Medicine
A
2/27/2023
My Alai™ Multisystem Support
408964
Medicine
A
5/15/2023

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
UBICOENZYME
02236503
Liquid - Oral
8 D
2/6/1998
DISCOMPEEL
02236490
Liquid - Oral
10 D
2/6/1998
HEPAR COMPOSITUM
02236496
Liquid - Oral
12 D
2/6/1998

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.